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Despite much effort, the structural features of the surface molecules responsible for
antigen recognition by thymus-derived (T) cells remain unclear (l, 2) . Progress in this
area will in part depend on the availability of homogeneous T cells from which to
isolate and purify T cell receptor molecules in quantities sufficient to characterize
them. With the advent of recent technology, the development ofT cell clones (3), and
the description of mitogen-induced T cell growth factors (TCGF; 4, 5),t it has become
possible to generate and maintain clones of antigen-specific T cells indefinitely in
culture in appreciable numbers.
In this communication, we provide a preliminary characterization of long-term-
cultured lines and clones of cytotoxic T lymphocytes (Tc) with specificity directed to
determinants of the Igh-lb immunoglobulin (Ig) allotype. These cell lines and clones
were initiated by repeated stimulation of Igh-ló-immune BALB/c spleen cells with an
Igh-lb-producing myeloma (6), and subsequent maintenance in vitro in medium
supplemented with mitogen-induced growth factors.
These cloned allotype-specific Tc are unique in that their cytotoxic activity can be
inhibited by soluble antigen, i.e., Igh- l b. In view of the available extensive knowledge
of the Igh-l b molecule, the antigen in this system, it seems likely that these allotype-
specific Tc will prove to be useful starting material for both detailed studies of killer
T cell functions and for molecular characterization of their receptors.
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T LYMPHOCYTES SPECIFIC FOR
IMMUNOGLOBULIN ALLOTYPE
II. Cloned Igh-l ó-specific Cytotoxic T Cells*
Materials and Methods
All of the techniques have been described in the accompanying paper (6) with the following
exceptions:
Long-Term Lines and Clones of Tc Cells.
￿
Procedures similar to those described by others (7-9)
were employed to initiate continuous long-term lines of killer cells. Spleen cells from BALB/c
mice immunized with Igh-lb myeloma proteins were restimulated in vitro three times in
succession at 10-14-d intervals. The number of responderspleen cellswas 5 X 106, 1 X 106, and
0.2 X 106cells/ml for the primary, secondaryand tertiary cultures. Afterthethirdrestimulation,
the remaining cells were cultured (10"-105 cells/ml) without further antigen in medium
supplemented with 30% (vol :vol) TCGF (supernate from BALB/c spleen cells cultured for 36-
* Supportedby grants AI-10961, AI-13323, CA-09140, CA-04946,CA-06927, CA-15822, and RR-05539
from the U.S. Public Health Service, grant IN-140 from The American Cancer Society, and by an
appropriation from the Commonwealth of Pennsylvania.
'Abbreviations used in this paper: LPS, lipopolysaccharide; MHC, major histocompatibility complex; Tc,
cytotoxic T cells; TCGF, Tcell growth factor.
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48 h with 5 ltg/ml concanavalin A). Clones were established by limiting dilution procedures in
microtiter plates using syngeneic feeder cells (2 X 104 peritoneal cells/well) in medium
supplemented with TCGF (30%, vol:vol) . All clones were selected from plates with <10%
positive wells. The cloning efficiency from primary cultures was 1-10%; in the preparation of
subclones it was >60%.
Miscellaneous Techniques.
￿
Ig were radiolabeled with
1251 by the chloramine T procedure (10)
to specific activities of 2 X 106-12 X 106 cpm/g,g of protein.
Anti-Thy-1 .2 antiserum was prepared by repeated immunization of AKR/J mice with
C3H/J thymus cells. For removal of T cells, 0.2 ml of this antiserum was added to 2.5 X 107
cells. After 30 min on ice, the cells were washed twice and resuspended in 2 ml guinea pig
serum (1 :7 dilution), as a source of complement, and incubated for 45 min at 37°C.
Derivation and Lytic Potency of Allotype-specific Tc Cell Lines and Clones.
￿
Long-term
BALB/c anti-Igh-l b Tc cell lines were initiated as described above and tested for lytic
activity at various times against CB101 targets. Fig. 1 illustrates the time-course of
the cytolytic activity of three such independent Tc lines. Without cloning, many of
the Tc lines eventually lose their cytolytic activity, as seen with the T2 line. However,
in some cases it is possible to maintain cytolytic activity for long periods of time
without cloning, as with the T4 cell line.
At 1 .5 mo after initiation, the T10 line was cloned by limiting dilution, and two
cytotoxic clones (T10.1A and T10.1B) were selected. Then at 3.5 mo, T10.113 was
subcloned, yielding the clones T 10.1B.2A, T 10.1 B.2C, and T10.113 .213. Fig. 2 illus-
trates the relative potency of these lines and clones compared with primary Tc
populations, immune spleen cells that have been restimulated in culture only once. It
is evident that Tc lines and clones are 30-100 times more potent than primary Tc
populations.
These long-term cell lines and clones have been identified as T cells by their
sensitivity to anti-Thy-1.2 and complement treatment (Table I).
Lytic Speciftcity.
￿
The functional specificity of these Tc clones is depicted in Fig. 3.
These T cells exhibit the same specificity as primary Tc populations (6) . That is, they
are lytic for CB101 cells and relatively nonlytic for CB101NP, (non-Igh-lb-producing
variant), U10 (Igh- 18), and S10P (Igh-4b) target cells and mitogen-induced BALB/c
blast cells. The T10.1B.2C clone is distinct from its sister subclones in that it is
generally more lytic for all targets tested.
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FIG. 2.
￿
Lytic potency ofthree clones from the T10 line, andof the T4 line compared with primary
cultures ofallotype-specific Tc.
Abolition of Cytotoxic Activity in Long-Term Allotype-specific Tc Lines with
Anti-Thy-1.2 and Complement
TABLE I
* Before treatment with antiserum and/or complement, the effector:target cell
ratio was adjusted to 40:1 for T4 and 10:1 for TIO.1B. No adjustments were
made in cell number after treatment.
The specificity of these Tc clones with respect to major histocompatibility complex
(MHC) restriction is shown in two experiments in Fig. 4. Cloned Tc and primary
cultures of anti-Igh-lb Tc were tested on "'Cr-labeled CB101 (Igh-1 b, H-2d), CB101NP
(H-2d), and B79 (Igh-lb, H-2) target cells. The latter is a plasmacytoma, BEPC79,
derived from CXBE mice by Dr. M. Potter, National Cancer Institute. As expected,
CB101NP targets were not lysed significantly; however, the T10.1B.2C clonedisplayed
appreciable lytic activity on B79, the Igh-lb expressing H-2b target cell.
Inhibition of Cloned Allotype-specific Tc by Soluble Igh-1b.
￿
In an effort to define better
the specificity of these allotype-specific Tc clones, the effect of preincubation of the
T10.1B.2A clone with various Ig preparations was examined. As demonstrated in
Table II, affinity-purified Igh-l" protein dramatically reduces the lytic capacity of
T10.1B.2A without affecting an unrelated allo-MHC-specific Tc population. This
effect is Ig allotype-specific, because Igh-l', Igh-4b, and Igh-48 did not inhibit lysis.
1251-labeled proteins were found to be far more efficient in causing this effect, whereas
much higher concentrations (1-10 mg/ml) of unlabeled Igh-lb were required to
achieve the same results; and labeled Igh-lb preparations did not inhibit the lytic
activity of primary cultures of anti-Igh-lb killer cells (Table III).
Percent specific lysis
treatment of
of CB101 targets after
effectors with*
Tc effectors
Complement
Anti-Thy-1.2 +
Complement
T4 71 11
T10 .IB 60 3494
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Lytic specificity of three clones and two lines of allotype-specific Tc tested on a variety of
different targets .
Mechanism of Igh-l b Inhibition of Tc Function .
￿
Efforts were made to quantitate the
direct binding of soluble Ig with these Tc clones . Radiolabeled Igh-la and Igh-lb
preparations (30-100 ,ug/ml) were incubated with T10.1B.2A cells for 60 min at
37°C . The cells were then washed extensively and the amount of bound Ig was
determined . The cytotoxic activity of theT cells after this treatment was then assessed .
Table IV demonstrates that there was no appreciable difference in the binding of
Igh-l b and Igh-la even though Igh-l b markedly inhibited lytic activity against Igh-lb
targets .
Table V explores the effect of temperature dependency of the lytic inhibition with
soluble Ig proteins . For these experiments, killer populations were incubated with or
without Igh-l" protein at 4 or at 37 °C for 40 min, washed, and then incubated with
5'Cr-labeled CB101 target cells . The results show that the inhibition of lysis of Igh-lb
targets with soluble Igh-lb proteins requires preincubation at 37 °C .
One explanation for the mechanism by which soluble Igh-lb inhibits the lytic
activity of the T10.1B.2A clone is that the Ig molecule serves to bridge two Tc cells,
causing one to lyse the other . This possibility of "autolysis" is supported by experi-
ments described in Table VI . T10.1B.2A killer cells were radiolabeled with 51Cr and
then incubated for 4 h with various Ig at 37°C . Supernates were then harvested, and
the percent of51Cr released was determined . As can be seen, Igh-lb induced significant
5'Cr release from T10.1B.2A cells without affecting lipopolysaccharide (LPS) blasts .H. R. SNODGRASS, M. J. BOSMA, AND D. B. WILSON
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￿
Top panel: comparison of lytic specificity of allotype-specific clones on Igh-lb targets
expressing the H-2d (self) or H-2b (allo) MHC haplotype. Bottom panel: this experiment was
repeated and included the use of CB101NP target and primary cultures of allotype-specific Tc.
Again, this effect was allotype-specific because Igh-1a and Igh-48 did not cause lysis of
anti-Igh-lb killer cells.
Suppression ofIgh-1b Expression In Vivo with an Allotype-specific Tc Line.
￿
Experiments
similar to those in the preceeding paper with primary cultures of allotype-specific Tc
populations were conducted to determine whether a long-term cultured line would
inhibit the expression of Igh-lb allotype in vivo. The data presented in Table VII
show that Tc cells of the T4 line, maintained in the absence of antigen in culture for
8 mo and showing 63% specific lysis on CB101 target cells, were able to inhibit
expression of the Igh-lb allotype over a 3-4-wk period by cotransferred C.B-17 spleen
cells in BALE/c mice. The suppression in this experiment was specific ; these animals
continued to express the C.B-17 Igh-4b allotype.
Discussion
Derivation of Tc Lines and Clones. The long-term Tc lines described here were
established and maintained by techniques similar to those described by others. This
involved three to four sequential antigen stimulations in culture, followed by further
maintenance without antigen in medium supplemented with concanavalin A-induced
TCGF. The cytotoxic activity of independently derived T cell lines varied greatly and496 ALLOTYPE-SPECIFIC T CELLS
TABLE II
Inhibition of Allotype-specific Tc Activity with Soluble Ig
* T10 .1B.2A anti-Igh-lbTc andBALB/c anti-B1/6mixed lymphocyte culture
cells were incubated with the various Ig preparations in the concentrations
indicated for 60 min at 37°C. They were washed twice, then tested for
residual lytic activity on CB 101 cells or on B6 concanavalin A blasts . The
effector:target ratios in the various experiments were 10-40:1 .
$ Inhibitors used were : phosphate-buffered saline (0.5% bovine serum albu-
min) ; chromatographically purified Igh-la, Igh-4a, and Igh-4b myeloma
proteins ; Igh-lb affinity-purified ascites fluid from R3-367, an anti-(3-nitro-
4-hydroxyphenyl)acetyl-producing hybridoma .
TABLE III
Inhibition with Soluble Ig ofLytic Activity by Primary and Cloned Allotype-
specific Tc
Percent specific lysis after treatment of
* 1251-labeled proteins were used as inhibitors ; effectomarget cell ratios 20 :1
forT10 .1B.2Aand60 :1 for primary anti-Igh-l b Tc ; other conditions were as
in Table II .
it was not necessarily stable (Fig . 1) . It seems likely that the loss of cytotoxic activity
involves overgrowth of the cultures with noncytotoxic cells that are apparently less
adherent than Tc . Tosome extent, loss of lytic activity can be minimized by discarding
the nonadherent subpopulation . Such a technique was used in these studies to
maintain the T4 line (Fig. 1) .
Cloned Tc were obtained from long-term lines by limiting dilution techniques . On
a cell for cell basis, these Tc clones were 30-100 times more cytotoxic than primary
Tc populations (Fig. 2) . At the time of these experiments, the T4 lines had been in
culture for ^-8 mo, and although it was not intentionally cloned, it may have "cloned
itself" because it is as cytotoxic as the three clones derived from the T10 line .
Lytic Specificity .
￿
The T cell lines (T4 and T10), and the clones (T 10.1B.2A,
Percent specific lysis after treatment of Tc
effectors
Ig
Inhibitor
concentra-
tion$
Labeled T10.1B.2A
BALB/c
anti-B6
Experi- 1 2 3 4 1 2 ment
PBS 26 62 42 43 48 55
Igh-lb (30pg/ml) + 3 16 20 52
(60pg/ml) + 4 10 39
(90pg/ml) - 45
(9 mg/ml) - 4 5 34
Igh-1* (50pg/ml) + 21 50 40 50
Igh-4b (21 pg/ml) + 24 62 46 50 44 56
Igh-4* (40pg/ml) + 60 50
Inhibitor Ig*
T10.1B.2A
effectors
Primary anti-Igh-lb
PBS 62 52
Igh-lb (33 ttg/ml) 16 48
Igh-4b (50 pg/ml) 62 54H. R. SNODGRASS, M. J. BOSMA, AND D. B. WILSON
TABLE IV
Direct Binding ofSoluble Ig to Allotype-specific Tc Cells and Its Effect Upon
Cytolytic Activity
* 126I-labeled myeloma proteins (30-100 tlg/ml) were incubated with
T10.1B.2B cells for 60 min at 37°C, washed three times, and the percentage
bound was determined. The cells were then assayed for the ability to lyse
C13101 target cells.
TABLE V
Temperature Dependency ofthe Inhibitory Effects ofSoluble Igh-1b Upon
Allotype-specific Tc Cells
* T10.1B.2A cells (experiment 1, 5 X 105; experiment 2, 2.5 X 105) were
incubated with 40 Ftg/ml Igh-lb affinity-purified hybridoma protein for 60
min at 4 or 37°C. The cells were washed once and 1 X 10° 5'Cr-labeled
CB101 cells were added. After a 4-h incubation at 37°C, the percent specific
lysis wasdetermined.
TABLE VI
Igh-1 b-induced Autolysis ofAnti-Allotype Tc Cells
* Igh-l b was affinity-purified R3-367 protein, whereas Igh-1° and Igh-4b were
chromatographically purified U10and MOPC300 protein, respectively.
TIO.1B.2A and LPS blast cells were labeled with 'Cr and incubated with
various Ig (10 mg/ml) for 4 h at 37°C, after which supernates were harvested
and the percent specific chromium release was calculated. The spontaneous
release ofboth targets was 10-20%.
Ig*
Percent specific
T10.1B.2A
5'Cr release oft
LPS blasts
1 2 3 2
Igh-l b 19 5 34 5
Igh-la 0 2 5 3
Igh-4b ND 2 8 4
Experiment Myeloma protein Percent of input
Igbound
Percent specific
lysis ofCB101
target
A None - 50
Igh-I b 0.6 -0.1
Igh-la 0.7 60
B None - 25
Igh-l b 0.5 11
Igh-18 0.4 26
Incubation of Tcells
with Igh-lb at*
Percent specific lysis
Experiment 1
of CB 101 targets
Experiment 2
No Ig at 4°C 39 28
No Ig at 37°C 40 26
4°C 38 26
37°C 5 10498
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TABLE VII
Suppression of Igh-1 b Allotype Expression In Vivo with Cloned Allotype-
specefc Tc
* Nylon wool-purified T cells (5 X 106) form normal or Igh-lb-immune
BALB/c spleens, or Tc cells (1 X 10) from the Ion term (8 mo) T4 line
were cotransferred with C.B-17 spleen cells (5 X 10 into irradiated (550
rad) BALB/c recipients. The presence of C.B-17 allotypes was monitored
weekly. The T4 line showed 63% specific lysis at an effectontarget ratio of
20:1 on "'Cr-labeled CB101 cells at this time.
T10.1B.2C, and T10.1B.2D) show specificity patterns of lysis on different target cells
similar to those observed with the primary Tc populations from which the clones
were derived (Fig. 3). CB101 cells (Igh-lb) were lysed, but the nonproducing variant
CB101NP, the U10 (Igh-1a), S10P (Igh-4b) cells, and mitogen-induced BALB/c blasts
were not. Such a lysis pattern and the fact that affinity-purified Igh-lb protein was
used as the priming immunogen (6) together suggest that the specificity of these Tc
clones is directed to determinants of the Ig-1b Ig molecule.
Perhaps the strongest evidence for the Ig allotypic specificity of these Tc clones
comes from the observation that purified Igh-Ib will specifically inhibit the cytotoxic
activity of Tc (Table II). Purified Igh-1a, Igh-4b, and Igh-4a failed to inhibit the
activity of anti-Igh-lb Tc.
The results of our experiments on the question of MHC restriction must be regarded
as preliminary. Two of the three clones display an unambiguous preference for Igh-lb
targets of the self, H-2d, haplotype. The third shows the ability to cause extensive lysis
of Igh-l b-expressing targets of the H-2b haplotype as well. At this point, however, it
would be premature to conclude that this clone shows an unrestricted specificity for
Igh-lb; alternatively, it may be partially cross-reactive on the H-2b haplotype. A more
extensive sampling of Igh-lb targets with a variety of different MHC haplotypes
would help to resolve this question, but these are currently'unavailable.
Mechanism of Inhibition by Soluble Igh-1 b.
￿
The finding that soluble Ig can inhibit
lysis of Igh-lb targets has several interesting aspects that must be taken into account
when considering the possible mechanisms involved. First, preincubation of the T
cells with Ig is required; soluble Igh-lb does not inhibit cytotoxic activity when added
during the assay. This is consistent with findings in other cytotoxic systems (2, 11) .
Second, incubation at 37°C is required (Table IV). Third, there is no demonstrable
specific binding of Igh-Ib (Table III) .
The failure to show specific binding of Igh-lb proteins to these Tc clones may
indicate that receptors are shed into the medium or that they are so few in number on
the cell surface that they are not detectable by binding studies. Once Igh-l b binds to
T cells by whatever means, e.g., via F, receptors or by nonspecific adsorption, the cells
then become lysable by surrounding Tc, resulting in allotype-specific autolysis (Table
V) . Such a possibility suggests that these allotype-specific Tc should be able to lyse
Tcell population*
Number ofanimals/total
Igh-Ib or Igh-4b 3-4 wk after
Igh-1 b
expressing
cell transfer
Igh-4b
Normal spleen 5/5 5/5
Immune spleen 0/5 5/5
T4 0/5 5/5This study describes long-term-cultured lines and clones of cytotoxic T cells (Tc)
with specificity for determinants of the Igh-l b immunoglobulin allotype. These Tc
clones were initiated by repeated stimulation of immune spleen cells from BALB/c
mice with an Igh-lb-producing myeloma, and then they were maintained in medium
supplemented with mitogen-induced growth factors in the absence offurther antigenic
stimulation. The lytic potency of these clones was 30-100-fold greater than the
primary cultures from which they were derived, and specificity studies showed them
to be lytic for Igh-lb targets and not for targets expressing Igh-l a or Igh-4b, nor the
lipopolysaccharide blasts. Finally, soluble preparations of Ig were tested for their
ability to block lysis of labeled Igh-lb-expressing targets. The results showed that
Igh-lb and not other immunoglobulin allotypes or isotypes could block lysis, and that
the mechanism of lytic inhibition is due to Igh-l b-induced autolysis of the killer cells.
Receivedforpublication 20 April 1981.
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any neutral third party target cell, provided it has first been coated with Igh-l b
proteins. However, preliminary attempts to couple Igh-lb to neutral target cells, using
chromic chloride or via F. receptor binding, have not yielded positive results.
Suppression of Igh-1b Expression In Vivo with Allotype-specific Killer Cells.
￿
Aside from
questions of the proximal target and the specificity of suppressor T cell activity, it
remains to be determined whether a lytic mechanism is involved in allotype suppres-
sion. To some extent this possibility is supported by the finding (Table VII) that a
clone of allotype-specific T cells, lytic for Igh-l b-expressing targets in vitro, is also able
to inhibit expression of Igh-lb in vivo. In our view, these data raise the possibility that
some aspects of allotype suppression and thus, of Ig regulation in general, may be
mediated in vivo by killer T cells. However, it would not be prudent to consider that
all suppressor T cells function via a lytic mechanism (12) . Moreover, the demonstra-
tion in this paper that a T cell line exerts suppressor T cell activity in vivo need not
necessarily imply that lysis and suppression are manifestations of the same function
detected with different assays; alternatively, they could represent different functions,
involving different mechanisms, of the same cell.
The above conclusion, that suppressor T cells can induce and/or maintain allotype
suppression, supports the conclusion drawn in a previous paper (13) that allotype-
bearing B cells are a target of T cells in allotype-suppressed mice.
Summary
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